ARCHIVES

DCCR Free Up $5 Million; New Policy Limits Core Support

This article is from The Cancer Letter archive.

Vol. 02 No. 45 | November 5, 1976

Download PDF Visit The Full Archive

Related Articles

Avon 1995 Grant Application Available

December 2, 1994

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money

August 31, 1979

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

February 6, 2004

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008

Bill Introduced To Ban Smoking From All Flights

March 24, 1989